isr'obot mona lisa product presentation- june 2016
TRANSCRIPT
iSR’obot TM Mona Lisa
ZICOM GROUP
• Founded in 1978
• Listed on the ASX.
• Global Workforce > 700
• Presence in Singapore (HQ), Australia, Indonesia, Thailand, China, USA
• Enterprise 50
• Singapore 1000
• ISO 13485 & 9001
Key Information
Marine, Oil & Gas ConstructionPrecision Engineering & Technologies (PET)
2
(ASX: ZGL)
• Sales • R&D• Manufacturing
• Australia-Wide Service Support
Overview of iSR’obotTM Mona Lisa
The iSR’obot Mona Lisa is a
Robotic Assisted System .
• Transperineal Prostate Biopsy
• Automated Biopsy Positioning
• Unrestricted Dual Cone Coverage
• MRI-Ultrasound Fusion Capability
• HSA, CE, FDA and TGA Approved
3
Automated Robotic Positioning from 3D Biopsy Plan
• Biopsy Planning on Real-time Ultrasound Transverse
Images
• Review of Biopsy Plan on 3D Ultrasound Model
• Automated Robotic Arm Guides Biopsy Needle to Each
Planned Biopsy Core via Perennial Skin
• Ease of MRI Cognitive Planning
• Consistent and Repeatable Biopsy Precision
Automated Needle Trajectory
Automated Needle Depth
Biopsy Planning on Real-time Ultrasound
Biopsy Plan Review on 3D Model
Automated Robotic Needle Positioning based on Biopsy Plan
4
Unrestricted Dual Conical Coverage
Horizontal rotational movement (top view)
Vertical rotational movement (side view)
• Absence of a Grid Template to Restrict Biopsy
Sampling
• Good access to Prostate Apex and Anterior
• Minimal Skin Puncture
• Avoids Urethra
• Minimize Pubic Arch Interference
Prostate
Pivot Points Perineal skin
Intervention angles
2 Puncture Points on Perineum Skin
5
MRI-US Fusion with Automated Robotic Guided Biopsy
6
� Elastic MRI-Ultrasound 3D Model Registration
� Fusion-Guided Biopsy Planning
� Robotic Lesion Targeted Biopsy
Fused 3D Model with Marked Lesion
Automated Robotic Needle Positioning to Targeted
Tumor
Lesion Marked MRI Model
Real-time Ultrasound Model
Workflow - MRI-US Fusion Targeted Biopsy
Operative - Urologist
US Scan with Robot
patient3D US image
Prostate Modeling
US prostatemodel
Import MRI Data
Fusion Guidedbiopsy
Biopsy Execution
BiopsyReport
MRI Scan Prostate Modeling
Pre-operative – Radiologist/UrologistLesion Marking
7
Minimal Prostate Movement with Probe Sheath
PZCZ
TS
AFZProstate
Probe Sheath
The Probe Sheath supports the Prostate during biopsy.
This Minimizes Prostate Movement, enabling Accurate Biopsy Targeting
8
Journals & Conference Presentations
9
AUA 16-21 st May 2014 The Journal of Urology, Vol. 191, No. 4S
Supplement
Conference Presentations
10
34th SIU 12-14th October 2015 AUA 15-19 th May 2015
Conference & Preliminary Studies
11
Patients:
55 men with only one non-palpable suspicious lesion in multi-parametric magnetic resonance imaging (mpMRI) after prior negative 12-core transrectal ultrasound-guided biopsy
Results :
• 34 out of 55 patients (61.8%) were diagnosed with Prostate Cancer .
• 29 out of 34 (85.3%) Prostate Cancer were clinically significant intermediate- or high-risk cancers.
69th USANZ 16-19th April 2016 Results from Preliminary Study from Clinical Partners
in Germany
In the News
SINGAPORE
GERMANY
12
Worldwide
Singapore
Singapore General Hospital
- Prof. Christopher Cheng
National University Hospital
Germany
Universitätsklinikum Tuebingen
- Prof. Arnulf Stenzl
Universitätsklinikum Freiburg
Australia
Epworth Hospital, Melbourne
USA
NYU Langone Medical Center
- Prof. Samir Taneja
United Kingdom
Charing Cross Hospital, Imperial College Healthcare
Italy (Clinical Demos)
Arcispedale Santa Maria Nuova, Reggio Emilia
Ospedale San Lazzaro, Alba
Ospedale San Bortolo, Vicenza
Hesperia Hospital, Modena
Ospedale Maggiore S Giovanni, Torino
13